When should patients being treated for acute myeloid leukemia get a COVID-19 vaccination booster?

During the EHA 2022 Congress, Know AML spoke with Luis-Esteban Tamariz-Amador, University of Navarra, Pamplona, ES. We asked, When should patients being treated for acute myeloid leukemia get a COVID-19 vaccination booster.

Tamariz-Amador begins by highlighting the increased risk of developing severe COVID-19 for patients with hematologic malignancies, and the varying risks among different types, with patients with acute myeloid leukemia being at a particular high risk. Tamariz-Amador also notes that the likelihood of the COVID-19 vaccine inducing seroconversion is also increased for patients with acute myeloid leukemia compared to lymphoproliferative disorders or multiple myeloma. Finally, Tamariz-Amador discusses the number of doses, vaccine type, and when to get a vaccination booster.